Weigao Intervention Receives Ukrainian Medical Device Registration Certificate for Its Proprietary Metallic Drug-Eluting Stent System
Kinhely
Cardiovascular Interventional Device R&D and Production Company
Recently, the metal drug-eluting stent system independently developed by Kinhely Bio-Tech Co., Ltd., a subsidiary of Weigao Intervention Group, has passed the review of Ukrainian regulatory authorities and obtained the Ukraine medical device registration certificate, marking that its product has officially gained market access qualifications in Eastern Europe.
Weigao Intervention always adheres to the core concept of innovation-driven development and strictly follows international quality standards. This certification not only represents the company's comprehensive capabilities in R&D, production, and compliance management but also demonstrates its firm commitment to serving patients worldwide.
In the future, WEGO Intervention will continue to focus on the international market, increase R&D investment, and improve product quality in order to serve global patients with higher-quality and safer products. This effort will lay a solid foundation for Chinese medical devices to set sail overseas and firmly establish themselves in the global market.
